Research

Published research, patent portfolio, and ongoing governance failure analysis. SovereignClaw is built on peer-reviewed foundations.

This page is the evidence layer behind the product. SovereignClaw is positioned as an AI agent safety platform, but the underlying claims are anchored in published research, a patent portfolio, and an ongoing public record of governance failures. If you are evaluating the product technically, pair this page with the architecture and security pages. If you are evaluating it operationally, compare the evidence model to the compliance mappings.

Published Research

The SovereignClaw architecture, security properties, and enforcement model are documented in a research paper available on SSRN and DOI-registered on Zenodo:

What the paper covers

The paper explains why agent safety breaks down when execution is treated as a follow-on concern instead of a runtime boundary. It formalizes deterministic execution control, describes the receipt and ledger model, and outlines the security properties that make unsafe operations structurally unreachable instead of merely discouraged.

Patent Portfolio

SovereignClaw's current patent portfolio is tracked below using the application numbers, filing dates, internal references, provisional numbers, exact titles, and inventor names provided for the pending filings.

Why the patents matter for buyers

The patent portfolio is not just defensive IP. It also signals where the company believes the core novelty lives: authenticated intent resolution, deterministic governance at runtime, and hardened rails for high-risk enterprise actions. That matters when security and legal teams are assessing whether the platform has a differentiated approach to AI execution control.

ApplicationFiling DateInternal RefProvisionalTitleInventor
7498172703/23/2026-64/014,664Systems and Methods for Multimodal Emotional Signal Capture, Fusion, and Attested Calibration in AI Training PipelinesJames Dale Benton
7448369102/14/2026ExecLayer-DetGate-00163/983,308Systems and methods for deterministic execution-bound governance with cryptographic authorization binding, threshold authority control, and adversarial hardening.James dale Benton Jr.
7380945112/31/2025-63/952,140SYSTEMS AND METHODS FOR GENERATIVE OPS DYNAMIC GENERATION AND EXECUTION OF OPERATIONAL SOFTWARE VIA INTENT RESOLUTION AND INTERMEDIATE SCHEMA REPRESENTATIONMr. James Dale Benton Jr.
7276306110/20/2025-63/901,870Voice Activated Automotive Parts Identification and Advisory System with Hands Free Kiosk InterfaceMr. James dale Benton Jr.

Governance Failure Radar

Tracking Every Public AI Governance Failure

ExecLayer documents every public AI governance failure, analyzes root cause, and shows how deterministic runtime controls would have prevented it. That ongoing failure analysis gives teams a practical bridge between theory, architecture, and deployment risk.

View the Governance Failure Radar

Ongoing Analysis

Follow ongoing governance failure analysis and SovereignClaw development on the ExecLayer Substack:

How to use this material in evaluation

The fastest way to use this section in a buying process is to read the paper for the core model, review the radar for concrete failure cases, and then connect both to the deployment tiers and evaluation process. That gives technical, security, and business stakeholders a shared frame for why the product exists.

Request Early Access

Frequently Asked Questions

Where is SovereignClaw research published?
SovereignClaw research is published on SSRN (ID 6290760) and DOI-registered on Zenodo.
What is the Governance Failure Radar?
The Governance Failure Radar documents every public AI governance failure, analyzes root cause, and shows how deterministic runtime controls would have prevented it. Published on ExecLayer's Substack.
Are SovereignClaw patents published?
Four patent applications are pending: USPTO 74981727 (filed 03/23/2026; provisional 64/014,664), USPTO 74483691 (filed 02/14/2026; provisional 63/983,308), USPTO 73809451 (filed 12/31/2025; provisional 63/952,140), and USPTO 72763061 (filed 10/20/2025; provisional 63/901,870).